|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |

Protein Laboratory, Institute of Molecular Pathology, University of Copenhagen, Denmark
1 Department of Pharmacology, University College Dublin, Belfield, Dublin 4, Ireland
* Present address: MRC Laboratory for Molecular Cell Biology, University College London, United Kingdom
Author for correspondence: (e-mail: bock{at}plab.ku.dk)
Accepted October 12, 2001
Cell migration is required during development of the nervous system. The regulatory mechanisms for this process, however, are poorly elucidated. We show here that expression of or exposure to the neural cell adhesion molecule (NCAM) strongly affected the motile behaviour of glioma cells independently of homophilic NCAM interactions.
Expression of the transmembrane 140 kDa isoform of NCAM (NCAM-140) caused a significant reduction in cellular motility, probably through interference with factors regulating cellular attachment, as NCAM-140-expressing cells exhibited a decreased attachment to a fibronectin substratum compared with NCAM-negative cells. Ectopic expression of the cytoplasmic part of NCAM-140 also inhibited cell motility, presumably via the non-receptor tyrosine kinase p59fyn with which NCAM-140 interacts.
Furthermore, we showed that the extracellular part of NCAM acted as a paracrine inhibitor of NCAM-negative cell locomotion through a heterophilic interaction with a cell-surface receptor. As we showed that the two N-terminal immunoglobulin modules of NCAM, which are known to bind to heparin, were responsible for this inhibition, we presume that this receptor is a heparan sulfate proteoglycan. A model for the inhibitory effect of NCAM is proposed, which involves competition between NCAM and extracellular components for the binding to membrane-associated heparan sulfate proteoglycan.
Key words: NCAM, Cell motility, Glioma, Heparan sulfate proteoglycan, Cell adhesion
This article has been cited by other articles:
![]() |
T. E. Werbowetski-Ogilvie, N. Y.R. Agar, R. M. Waldkircher de Oliveira, D. Faury, J. P. Antel, N. Jabado, and R. F. Del Maestro Isolation of a Natural Inhibitor of Human Malignant Glial Cell Invasion: Inter {alpha}-Trypsin Inhibitor Heavy Chain 2 Cancer Res., February 1, 2006; 66(3): 1464 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dityatev, G. Dityateva, V. Sytnyk, M. Delling, N. Toni, I. Nikonenko, D. Muller, and M. Schachner Polysialylated Neural Cell Adhesion Molecule Promotes Remodeling and Formation of Hippocampal Synapses J. Neurosci., October 20, 2004; 24(42): 9372 - 9382. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seidenfaden, A. Krauter, F. Schertzinger, R. Gerardy-Schahn, and H. Hildebrandt Polysialic Acid Directs Tumor Cell Growth by Controlling Heterophilic Neural Cell Adhesion Molecule Interactions Mol. Cell. Biol., August 15, 2003; 23(16): 5908 - 5918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Muench, J. V. Ratcliffe, M. Nakanishi, H. Ishimoto, and R. B. Jaffe Isolation of Definitive Zone and Chromaffin Cells Based upon Expression of CD56 (Neural Cell Adhesion Molecule) in the Human Fetal Adrenal Gland J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3921 - 3930. [Abstract] [Full Text] [PDF] |
||||